✦ LIBER ✦

Inhibition of platelet function by abciximab or high-dose tirofiban in patients with STEMI undergoing primary PCI: a randomised trial

✍ Scribed by J. W. van Werkum; W. B. M. Gerritsen; J. C. Kelder; C. M. Hackeng; S. M. Ernst; V. H. M. Deneer; M. J. Suttorp; B. J. W. M. Rensing; H. W. M. Plokker; J. M. ten Berg

Book ID: 112994165
Publisher: Bohn Stafleu van Loghum
Year: 2007
Tongue: English
Weight: 164 KB
Volume: 15
Category: Article
ISSN: 1568-5888
DOI: 10.1007/bf03086018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Trial of Early Inhibition of Platelet

A Trial of Early Inhibition of Platelet Aggregation in Patients with Acute Coronary Syndrome (ACS) Undergoing Percutaneous Intervention (PCI): High Dose Tirofiban Bolus and Infusion Compared to Standard Dose Abciximab

✍ C.C.S. Lim; B. Chou; L. Roberts; V. Pandeli; A. Teh; Y.M. Cheong; C. Goods; M. R 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Sex-specific benefits of sirolimus-eluti

Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trial

✍ Giuseppe Ferrante; Patrizia Presbitero; Elena Corrada; Gianluca Campo; Leonardo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 419 KB

Randomized, double-blind comparison of e

Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting

✍ M. VALGIMIGLI; G. CAMPO; M. TEBALDI; M. MONTI; S. GAMBETTI; A. SCALONE; G. PARRI 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB